An active FK506-binding domain of 17,000 daltons is isolated following limited proteolysis of chicken thymus hsp56.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 7504525)

Published in Biochemistry on November 30, 1993

Authors

A W Yem1, I M Reardon, J W Leone, R L Heinrikson, M R Deibel

Author Affiliations

1: Department of Biochemistry, Upjohn Company, Kalamazoo, Michigan 49001.

Articles by these authors

Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48

Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature (1990) 3.81

Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52

Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (1990) 2.80

Antibodies specific to acetylated histones document the existence of deposition- and transcription-related histone acetylation in Tetrahymena. J Cell Biol (1989) 1.91

Cation binding to the integrin CD11b I domain and activation model assessment. Structure (1998) 1.90

Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem (1977) 1.81

Nucleotide sequence and expression of the capsid protein gene of feline calicivirus. J Virol (1991) 1.78

The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem (1992) 1.63

A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J Biol Chem (1991) 1.59

The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry (1994) 1.59

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56

The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem (1992) 1.55

The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure (1999) 1.54

Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52

The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem (1995) 1.48

Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry (1991) 1.48

An examination of the expected degree of sequence similarity that might arise in proteins that have converged to similar conformational states. The impact of such expectations on the search for homology between the structurally similar domains of rhodanese. J Mol Biol (1981) 1.44

The selective S-methylation of sulfhydryl groups in proteins and peptides with methyl-p-nitrobenzenesulfonate. J Biol Chem (1971) 1.41

The covalent and tertiary structure of bovine liver rhodanese. Nature (1978) 1.41

A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J Biol Chem (1984) 1.38

Complete amino acid sequence of pig kidney fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (1982) 1.37

Sequence of the bacteriophage SP01 gene coding for transcription factor 1, a viral homologue of the bacterial type II DNA-binding proteins. Proc Natl Acad Sci U S A (1984) 1.36

Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates. J Virol (1990) 1.33

Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem (1990) 1.32

Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J Biol Chem (1991) 1.29

Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J Biol Chem (1990) 1.29

Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease. Biochemistry (1990) 1.26

Active site cysteinyl and arginyl residues of rhodanese. A novel formation of disulfide bonds in the active site promoted by phenylglyoxal. J Biol Chem (1978) 1.24

Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins. Gene (1990) 1.24

Applications of thermolysin in protein structural analysis. Methods Enzymol (1977) 1.22

The covalent protein structure of insecticyanin, a blue biliprotein from the hemolymph of the tobacco hornworm, Manduca sexta L. J Biol Chem (1984) 1.21

Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol (1999) 1.21

Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method. Proteins (1996) 1.20

Purification, physical characterization, and NH2-terminal sequence of glutamine synthetase from the cyanobacterium Anabaena 7120. J Biol Chem (1981) 1.18

Purification and properties of methionyl-transfer-ribonucleic acid synthetase from Escherichia coli. Biochem J (1967) 1.18

Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus. J Biol Chem (1991) 1.16

Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem (1999) 1.16

Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies. J Protein Chem (1993) 1.14

Characterization of the protein-protein interactions determining the heat shock protein (hsp90.hsp70.hsp56) heterocomplex. J Biol Chem (1994) 1.14

Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Protein Sci (1992) 1.13

Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol (1993) 1.13

Anthranilate synthetase component II from Pseudomonas putida. Covalent structure and identification of the cysteine residue involved in catalysis. J Biol Chem (1978) 1.12

Silkmoth chorion proteins. Their diversity, amino acid composition, and the NH-terminal sequence of one component. J Biol Chem (1978) 1.12

Detection and kinetic behavior of preproinsulin in pancreatic islets. Proc Natl Acad Sci U S A (1978) 1.12

Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry (1986) 1.11

Purification and characterization of a low molecular weight acid phosphatase from bovine liver. J Biol Chem (1969) 1.09

Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease. J Biol Chem (1992) 1.08

Covalent structural analysis of yeast inorganic pyrophosphatase. J Biol Chem (1978) 1.07

CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem (1995) 1.07

On the alkylation of amino acid residues at the active site of ribonuclease. J Biol Chem (1966) 1.04

A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active. J Biol Chem (1991) 1.04

Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. J Biol Chem (1993) 1.03

Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates. Methods Enzymol (1994) 1.03

The nucleotide sequences of the 3'-terminal regions of papaya ringspot virus strains W and P. J Gen Virol (1990) 1.03

Targeting the HIV-protease in AIDS therapy: a current clinical perspective. Biochim Biophys Acta (2000) 1.03

Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease. J Biol Chem (1990) 1.03

FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts. J Biol Chem (1993) 1.03

Chloroplast and cytoplasmic enzymes 1, 2, 3. Subunit structure of pea leaf aldolases. Arch Biochem Biophys (1975) 1.01

The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. J Biol Chem (1993) 1.01

FK506 binding to the 56-kilodalton immunophilin (Hsp56) in the glucocorticoid receptor heterocomplex has no effect on receptor folding or function. Biochemistry (1993) 1.00

Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease. Protein Sci (1993) 0.99

Phosphorylation of rat hepatic fructose-1,6-bisphosphatase and pyruvate kinase. J Biol Chem (1980) 0.98

Purification of a high molecular weight human terminal deoxynucleotidyl transferase. J Biol Chem (1979) 0.98

HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res Hum Retroviruses (1992) 0.97

Sequence analysis of bovine lens aldose reductase. J Biol Chem (1990) 0.97

ABRF ESRG 2005 study: identification of seven modified amino acids by Edman sequencing. J Biomol Tech (2006) 0.96

The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase. J Biol Chem (1993) 0.96

Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. Biochemistry (1991) 0.96

The amino acid sequence of a testis-specific basic protein that is associated with spermatogenesis. J Biol Chem (1975) 0.96

The chemical basis for interfacial activation of monomeric phospholipases A2. Autocatalytic derivatization of the enzyme by acyl transfer from substrate. J Biol Chem (1988) 0.95

Biochemical properties of purified human terminal deoxynucleotidyltransferase. J Biol Chem (1980) 0.94

The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution. J Biol Chem (1990) 0.94

The covalent structure of bovine liver rhodanese. Isolation and partial structural analysis of cyanogen bromide fragements and the complete sequence of the enzyme. J Biol Chem (1978) 0.94

ABRF ESRG 2006 study: Edman sequencing as a method for polypeptide quantitation. J Biomol Tech (2007) 0.93

Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils. Biochim Biophys Acta (1987) 0.93

Tissue distribution and cellular localization of hsp56, an FK506-binding protein. Characterization using a highly specific polyclonal antibody. J Biol Chem (1992) 0.93

The biochemistry of pseudouridine. Prog Nucleic Acid Res Mol Biol (1966) 0.92

The native v-Raf.hsp90.p50 heterocomplex contains a novel immunophilin of the FK506 binding class. J Biol Chem (1994) 0.92

The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol Endocrinol (1994) 0.92